Treating cardiogenic shock with drug and mechanical support
Part of Heart & circulation clinical trials.
This trial is testing different approaches (medications and mechanical support) to help people with acute heart failure and cardiogenic shock (a sudden drop in the heart's pumping ability). It looks at how well these treatments work in a network of hospitals to improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are admitted to a cardiac intensive care unit (CICU) with suspected cardiogenic shock (the heart is not pumping enough blood).
- Your cardiogenic shock is not caused by recent heart surgery (post-cardiotomy).
- You do not have a major injury or a serious brain injury.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a “registry,” meaning it collects health information from people hospitalized with cardiogenic shock. It may help doctors better understand the condition and improve care over time.
This study tracks how well people with cardiogenic shock (a life-threatening drop in blood flow after a heart attack or heart failure worsening) do when treated with modern support devices and medicines.
This trial tests a treatment plan for people having a severe heart attack that causes cardiogenic shock, where the heart can't pump enough blood. The study uses a special heart pump to support patients during an emergency procedure to open blocked arteries.
This trial is a registry that collects information on diagnosis, treatment, and outcomes for people with cardiogenic shock (when the heart can't pump enough blood to the body). It may help doctors learn more about this condition and how to treat it better.
This trial tests if unloading the heart during ECMO support helps patients recover better from cardiogenic shock. It compares different ways to reduce the heart's workload.
This study looks at how people with cardiogenic shock (or very low blood pressure from heart causes) do after treatment in a specialized cardiovascular ICU. It also examines whether care by heart critical-care specialists affects outcomes.
Hear when a new Cardiogenic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.